University of Pennsylvania
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).
University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.
University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,423 total, page 11 of 29
Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)
NCT04460560
Impact of Nudges on Downloads of COVID-19 Exposure Notification Smartphone Apps: A Randomized Trial
NCT05080179
Biocontainment Device for Aerosol Generating Procedures
NCT04532112
Genetic Testing in Young Adults With Cancer Study
NCT04533555
Treating Primary Progressive Aphasia (PPA) Using tDCS
NCT04566731
COVID-19 Watch + COVID-19 Pulse
NCT04581863
Hepatocellular Carcinoma Surveillance in Cirrhotics
NCT04248816
Behavioral Economics and Mobility After Stroke (BE Mobile)
NCT04607811
Ferumoxytol Enhanced Hyperfine Low Field Strength MRI
NCT04721262
Patient-Portal vs Text-based Hypertension Monitoring Among Black Medicaid/Medicare Patients
NCT05186831
Nudges for Statin Prescribing in Primary Care
NCT04307472
Our Care Wishes - Dementia
NCT05033262
Acute Effects of Exogenous Ketone Ester Administration in Heart Failure
NCT04633460
Framing Clinical Trial Enrollment for Patients With Peripheral Artery Disease
NCT04536038
Gamification-Augmented Home-Based Exercise for Peripheral Artery Disease
NCT04536012
Pre-op Cognitive Behavior Therapy to Decrease Chronic Post-Surgical Pain in TKA
NCT04814992
Metabolomics of Obstructive Sleep Apnea
NCT04572269
Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates at a Large Retail Pharmacy
NCT04590066
Using Digital Data to Predict CHD
NCT04574882
Improving Inpatient Screening for Hepatitis C
NCT04525690
Digital Data in Mental Health Therapy
NCT04011540
Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates
NCT04565353
PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms
NCT05310409
COVID-19 SAFE Enrollment
NCT04506268
COVID SAFE: COVID-19 Screening Assessment for Exposure
NCT04508777
Cranial Blocks for Postoperative Anesthesia
NCT04749797
Evaluation of Microcirculatory Function and Mitochondrial Respiration After Cardiovascular Surgery
NCT05330676
User Acceptability of a Device-Based Opioid Overdose Intervention
NCT04530591
Prospective Evaluation of Facial Cosmetic Procedures
NCT03460158
FEnofibRate as a Metabolic INtervention for COVID-19
NCT04517396
Treating Primary Progressive Aphasia (PPA) Using High-definition tDCS
NCT04046991
Post-operative Cognitive Function Following Pelvic Floor Surgery
NCT04554550
Pilot Study of Esocheck in Eosinophilic Esophagitis
NCT04311970
Evaluation of a Decision Aid for Early Pregnancy Loss
NCT04410029
A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment
NCT06110494
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
NCT04405167
Increasing Engagement and Improving HIV Outcomes Via HealthMPowerment
NCT03678181
Cyclosporine in Patients With Moderate COVID-19
NCT04412785
Project Resurgence Communication Trial
NCT04418947
Natural History Study of Infantile and Juvenile GM1 Gangliosidosis (GM1) Patients
NCT04041102
A Trial of Project ImPACT in Early Intervention
NCT04729127
Mechanisms of Upper Airway Obstruction
NCT04322097
COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.
NCT04397757
COVID-19 Convalescent Plasma for Mechanically Ventilated Population
NCT04388527
Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19
NCT04379544
Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019
NCT04338009
The Effects of Online Single-Session Interventions on College Student Well-being
NCT04287374
Effects of Sugary Drink Warning Labels on Parent Choices
NCT04259385
Developing Oral LT3 Therapy for Heart Failure - HFpEF
NCT04111536
Role of Slow-wave Activity and Plasticity in MDD
NCT04150718
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 182 |
| Phase 2 | 157 |
| Phase 3 | 43 |
| Phase 4 | 87 |
Therapeutic Areas
What is open in the University of Pennsylvania pipeline
199 recruiting of 1,423 indexed (14% open); 982 completed (69%).
Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.